T3 Defense Inc. filings document material events for a Nasdaq-listed defense technology holding company, including operating results, acquisitions and dispositions, financing arrangements, debt exchanges, governance matters, capital-structure changes, and exchange-listing compliance. Recent Form 8-K disclosures identify the company's common stock and warrants, emerging growth company status, and securities registered on Nasdaq.
The filing record includes disclosures on note exchanges for common stock, cancellation of indebtedness, private-placement and material-agreement categories, shareholder voting matters, operating and financial results, and a Nasdaq minimum-bid compliance notice. It also documents portfolio-related transactions involving subsidiaries and investments, including Star 26 Capital, Water IO, and Zorronet-related asset disposition activity.
T3 Defense Inc. (DFNS) said it cannot file its Form 10-Q for the quarter ended September 30, 2026 by the prescribed November 16, 2026 due date because it needs additional time to complete disclosures and analyses. It intends to file on or before the fifth calendar day following the due date. The company anticipates significant changes from the corresponding 2025 quarter, when it generated no revenues, but cannot estimate results while its financial statements and independent accountants’ review remain incomplete.
T3 Defense Inc. (DFNS) common stock is directly held by Nexera Technologies Ltd., which reported 425,594 shares, or 9.99% of the class. Nexera reported sole voting and dispositive power over those shares, with no shared voting or dispositive power. The percentage is based on 3,834,775 shares outstanding as of November 5, 2026.
T3 Defense Inc. asks stockholders to approve four proposals at its November 30, 2026 special meeting: a Second 2026 Equity Incentive Plan with 1,275,000 shares available if approved; board authority for one or more reverse splits at ratios from 1-for-2 to 1-for-250 within two years; an equity award agreement for CEO and director Menachem Shalom; and authority to adjourn to seek additional proxies if needed.
If approved, the plan would permit options, restricted stock, restricted stock units and stock appreciation rights. Under Shalom’s proposed award agreement, quarterly share issuances would target 8% beneficial ownership on a fully diluted basis while he remains CEO or another officer or director; if he is no longer CEO or affiliated with T3, the agreement provides for shares to bring his ownership to 15%. No shares may be issued unless stockholders approve, including approval by a majority of votes cast by stockholders other than Shalom and his affiliates.
A reverse split would require the Board to proceed and file an amendment; the Board may abandon it before it takes effect. Authorized shares would remain unchanged, leaving more common shares available for future issuance. T3 says it regained compliance with Nasdaq’s $1.00 minimum bid price requirement after its July 2026 1-for-125 reverse split.
T3 Defense Inc. (DFNS) completed its acquisition of KeepZone AI Inc. on November 4, 2026, issuing 425,594 shares of common stock to Nexera Technologies Ltd. for all of KeepZone’s issued and outstanding shares. An amendment increased the purchase price to $1,539,800 and raised the beneficial ownership limitation on shares held by Nexera to 9.9%.
The shares were issued under an exemption from registration under Section 4(a)(2) and/or Rule 506 of Regulation D.
T3 Defense Inc. (DFNS) is asking stockholders to approve four proposals at a virtual meeting on November 30, 2026: a Second 2026 Equity Incentive Plan, discretionary reverse-split authority, an equity award for CEO and director Menachem Shalom, and authority to adjourn to solicit additional proxies. The board recommends a vote “FOR” each proposal.
If approved, the plan would make 1,275,000 shares available for awards. The board could effect one or more reverse splits at ratios from one-for-two to one-for-two hundred fifty within two years after the meeting, but could also abandon the split. T3 says it received a Nasdaq minimum-bid-price notice on May 5, 2026, and regained compliance after its closing price exceeded $1.00 from August 3 through August 14, 2026.
The proposed award would target Shalom’s beneficial ownership at 8% on a fully diluted basis each quarter for seven consecutive fiscal quarters, and provide additional shares to reach 15% if he stops serving as CEO or is no longer affiliated with T3. The award requires stockholder approval, including approval by a majority of votes cast by stockholders other than Shalom and his affiliates. The reverse split would not change authorized share counts or par value, and holders otherwise entitled to fractional shares would receive one whole share.
T3 Defense Inc. completed a private placement on October 22, 2026, selling 200 units for an aggregate purchase price of $10,000,000, or $50,000 per unit. Each unit consists of one share of Series B Convertible Preferred Stock and common stock purchase warrants; the warrants are initially to purchase up to 14,851 shares of common stock. The sale was made under a Securities Purchase Agreement dated February 24, 2026, with an accredited investor.
The company received $6,605,000 in net proceeds after deducting principal and accrued interest owed to the investor under a Term Note dated September 8, 2026, and paying Dawson James Securities Inc. a cash fee equal to 3.5% of gross proceeds under the Placement Agency Agreement. The preferred stock and warrants were issued under an exemption from registration under Section 4(a)(2) and/or Rule 506 of Regulation D, based in part on representations made by the investor.
T3 Defense Inc. agreed to acquire all issued and outstanding shares of KeepZone AI Inc. from Nexera Technologies Ltd. for an aggregate purchase price of $1,000,000, payable at closing in common stock and, if needed, pre-funded warrants. The agreement states a 4.99% beneficial ownership limitation; the accompanying press release states 4.9%. T3 Defense is not obligated to register the consideration shares for resale.
Nexera may receive a cash earn-out equal to 50% of KeepZone’s standalone net profit over 24 months, calculated on the first $10,000,000 of profit and capped at $5,000,000. On the 181st day after closing, additional shares are required only if Nexera still holds consideration shares, no resale registration statement covering them is effective, and T3 Defense’s Nasdaq trading price is below the closing-date reference price; the additional issuance must bring the market value of consideration shares issued to Nexera to $1,000,000. Closing is subject to customary conditions, including third-party consents and regulatory and Nasdaq requirements, and is expected on the second business day after satisfaction or waiver. Either party may terminate if closing has not occurred within 60 days after signing, subject to exceptions.
T3 Defense Inc. (DFNS) says it believes it has regained compliance with Nasdaq’s $10 million stockholders’ equity requirement after holders exercised approximately 96% of outstanding warrants as of September 30, 2026. The common warrants, issued in a $20 million private placement on February 24, 2026, were classified as liabilities and remeasured at fair value each reporting quarter. The reported warrant liability was approximately $24.5 million at December 31, 2025, and approximately $124.4 million at June 30, 2026; reported stockholders’ equity moved from approximately $42.5 million at March 31, 2026, to a deficit of approximately $19.7 million at June 30, 2026.
After giving effect to warrant exercises, the company reported pro forma stockholders’ equity of approximately $99.9 million. T3 Defense has asked Nasdaq to resolve the deficiency and confirm compliance. Nasdaq will continue monitoring; if the company does not evidence compliance in its next periodic report, it may be subject to delisting. The next report is its Form 10-Q for the quarter ending September 30, 2026.
T3 Defense Inc. registered up to 7,051,799 common shares for resale by selling stockholders: up to 1,980,198 shares issuable on conversion of Series B preferred stock and 5,071,601 shares issuable on exercise of common warrants. T3 is not selling shares and receives no proceeds from resales; it may receive proceeds from cash exercises of warrants. The preferred shares and warrants have beneficial-ownership blockers of 9.9% and 9.99%, respectively. Shares outstanding were 3,250,296 as of September 30, 2026.
T3 describes a shift from financial technology to aerospace and defense, with a portfolio of defense and aerospace businesses. As of June 30, 2026, it reported approximately $131 million in negative working capital, including $124 million in stock purchase warrant liabilities that will not require cash to extinguish, and a $19 million stockholders’ deficit. For the six months ended June 30, 2026, net operating loss was $7.2 million and net cash used in operations was $9.8 million. Management said its plans, including approximately $4.1 million in unrestricted cash and an equity line of credit, alleviate substantial doubt about the company’s ability to continue as a going concern.
T3 Defense Inc. (DFNS) registered up to 10,000,000 common shares for resale by Esousa Group Holdings, LLC. T3 may issue shares to Esousa under its committed equity purchase agreement, but receives no proceeds from Esousa’s resales. Separately, T3 may sell common stock to Esousa at its discretion, subject to the agreement’s conditions and the shares covered by this prospectus, for up to $250,000,000 in aggregate purchase price. The share block would represent approximately 75% of outstanding shares upon issuance, excluding applicable beneficial-ownership limitations; T3 had 3,250,296 shares outstanding as of September 30, 2026. The agreement bars T3 from directing a purchase that would take Esousa and its affiliates above 9.99% beneficial ownership.
For the six months ended June 30, 2026, T3 used $9.8 million of net cash in operations and said additional liquidity would be required for the next 12 months absent other action. Management concluded its plans alleviate substantial doubt about continued operations, including approximately $4.1 million of unrestricted cash and an active equity line with drawdown capacity exceeding projected annual operating cash needs.